ELS; MBN360 HEALTH
The Ministry of Health has firmly denied claims of a nationwide shortage of antiretroviral medicines (ARVs), responding directly to a press statement issued by the Network of Persons Living with HIV in Ghana (NAP+ Ghana) that suggested such a shortage exists.
Addressing the concerns raised, the Ministry said it had taken note of NAP+ Ghana’s press release but wished to categorically clarify the facts surrounding the availability of ARVs at health facilities across the country, while reaffirming its commitment to constructive engagement with the organisation.
The Ministry’s response comes at a sensitive moment for thousands of Ghanaians living with HIV, many of whom depend on consistent, uninterrupted access to antiretroviral therapy to manage their condition effectively.
The Ministry was unequivocal in rejecting the suggestion that antiretroviral medicines are unavailable in Ghana, stating that the drugs remain accessible at designated health facilities nationwide to support the continued treatment and care of persons living with HIV.
“It is not accurate that antiretroviral medicines are unavailable in the country. ARVs are available at designated health facilities across Ghana.”Ministry of Health
The Ministry explained that as part of its routine Procurement and Supply of Medical Commodities process, it is currently restocking supplies at the Medical Stores, with plans already far advanced to fulfil this obligation and ensure continued distribution to health facilities across the country.
Restocking Efforts Aimed at Sustained Availability
According to the Ministry, these restocking efforts are specifically designed to guarantee sustained availability and timely distribution of ARVs, alongside other essential health commodities, to facilities nationwide.
“These efforts are intended to ensure sustained availability and timely distribution of medicines and other essential health commodities to health facilities across the country.”Ministry of Health
It described the process as part of ongoing, routine supply chain operations rather than an emergency response to a shortage, framing the current restocking exercise as standard practice within its broader medicine procurement cycle.
The Ministry’s emphasis on the routine nature of this restocking appears intended to reassure the public that any temporary fluctuations in stock levels at specific facilities do not reflect a systemic breakdown in the country’s ARV supply chain.
No Medicines Expired at the Port, Ministry Clarifies
Addressing a separate claim that had circulated alongside concerns about shortages, the Ministry firmly rejected suggestions that antiretroviral medicines had expired while awaiting clearance at the port.
It maintained that it continues to work closely with relevant stakeholders to ensure the effective management and timely clearance of medical commodities entering the country.
By directly addressing this specific allegation, the Ministry appeared keen to prevent the spread of what it considers inaccurate information that could undermine public confidence in the availability and safety of HIV treatment medicines across the country.
The Ministry disclosed that it has already engaged the Network of Persons Living with HIV in Ghana, assuring the organisation of its open-door policy in addressing concerns relating to the availability and distribution of antiretroviral medicines.
This engagement, according to the Ministry, reflects its willingness to work collaboratively with stakeholder groups representing persons living with HIV, rather than dismissing their concerns outright.
The Ministry reaffirmed its commitment to constructive engagement with all stakeholders going forward, stating that this collaborative approach is essential to ensuring that persons living with HIV continue to have uninterrupted access to the medicines and services they require for their ongoing care.
Broader Commitment to Medicine Security
The Ministry’s response reflects a broader institutional effort to safeguard public confidence in Ghana’s essential medicines supply chain, particularly for a condition like HIV, where consistent access to antiretroviral therapy is critical to patient health outcomes and the prevention of treatment interruptions that could compromise viral suppression.
By publicly addressing both the shortage claims and the port expiry allegation in a single, detailed statement, the Ministry appears to be taking a proactive approach to managing public perception around a sensitive health issue, one that carries significant implications for thousands of Ghanaians currently on ARV treatment regimens nationwide.
Ministry Reassures the Public
In its concluding remarks, the Ministry of Health sought to reassure the public, particularly persons living with HIV, that it remains committed to safeguarding access to essential medicines.
It pledged to continue taking the necessary measures to ensure the availability and equitable distribution of antiretroviral medicines across all regions of the country, regardless of location or facility type.
With the Ministry having already initiated engagement with NAP+ Ghana, the coming weeks are likely to serve as a practical test of its assurances, as restocking efforts at the Medical Stores progress and supplies continue to reach designated health facilities nationwide.
Continued transparency from the Ministry, alongside sustained engagement with advocacy groups such as NAP+ Ghana, will remain central to maintaining public trust in the country’s HIV treatment programme, particularly as both parties work to align on the facts surrounding medicine availability and distribution nationwide.
